Westminster Stocks: Who's Best in Show?
If you're curious about how pet-related stocks are faring ahead of the Westminster Kennel Club 133rd Annual Dog Show -- and really, who isn't? -- have a gander.
Valentine's Stocks: Diamonds, DVDs or Frosting?
With Valentine's Day mere days away, stocks of companies that sell jewelry, chocolate and unmentionables were trading mixed Monday.
Glaxo Buys Rights to Idenix HIV Drug
GlaxoSmithKline has bought the licensing rights to an HIV drug candidate IDX899 from Idenix Pharmaceuticals.
McClatchy, Wall Street Journal to Cut Jobs
McClatchy's Fort Worth Star-Telegram issued a memo to employees Thursday announcing cost cuts that will include the elimination of positions.
Allergan Reports Saggy Profit, Jobs Cuts
Drugmaker Allergan said Wednesday its profit dropped in the fourth quarter and that it would cut 460 jobs.
Lilly's Sepsis Drug Draws FDA Scrutiny
The good cheer aroused by Eli Lilly's blood thinner prasugrel was tempered somewhat Wednesday by a report that the FDA was investigating an increased incidence of bleeding in another of the company's drugs, Xigris.
For Myriad Genetics, the Splice Is Right
Myriad Genetics shares soared after the biotech firm announced a healthy second quarter that beat analyst expectations.
More Pain at Belo
A.H. Belo announced Friday it will cut another 500 jobs.
Mead Johnson IPO: Baby's First Day a Winner
Investors cheered baby formula maker Mead Johnson's first day of trading after cutting the cord with Bristol-Myers.
'Staycation' Stocks for the Armchair Investor
These stocks could stand to profit from the growing trend toward stay-at-home time off.
Valentine's Day Winners and Losers
Find out how the stocks of companies that sell jewelry, chocolate and unmentionables performed Wednesday.
Valentine's Day Winners and Losers
With Valentine's Day just four days away, stocks of companies that sell jewelry, chocolate and unmentionables are not feeling the love.
